Digital Medicine
-
Digital Therapeutics: A Panacea for Care or Overvalued Health Tech?
Digital therapeutics will be one of the topics discussed at INVEST Digital Health scheduled for October 26 at Health Wildcatters headquarters in Pegasus Park in Dallas. Register today!
-
Overcoming obstacles in digital medicine
A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Court approves Otsuka’s bid to buy Proteus for $15M
A bankruptcy court in Delaware approved a stalking-horse bid from Otsuka to acquire Proteus Digital Health for $15 million. The company, which makes sensor that can be embedded in pills to track medication adherence, filed for bankruptcy in June.
-
Will Proteus’ pivot pay off?
Proteus, which makes tiny sensors that can track medication adherence, will no longer develop the technology in behavioral health medications for Otsuka Pharmaceutical. Instead, the startup is shifting its focus to oncology and infectious diseases, where it hopes its tech will have better traction.
-
Digital Medicine & Medtech Showcase convenes in San Francisco January 13–15, 2020
At the intersection of technology and medicine, the Digital Medicine & Medtech Showcase will offer more than 70 dedicated company presentations and 500+ attendees exclusively from the digital medicine and medtech sectors.
-
Startups, Devices & Diagnostics, BioPharma, Pharma
Digital medicine startup Proteus Digital Health pushes into oncology
Proteus’ new oral oncology drug is a digital version of capecitabine, a common chemotherapy medication often used to treat breast and gastrointestinal cancers.
-
Startups, Events, BioPharma, Pharma
Here’s Otsuka’s digital health strategy around mental health
Otsuka’s top U.S.-based leaders spoke about the company’s partnerships in mental health and how it is driving innovation in big pharma.
-
Otsuka, Proteus expand agreement around digital medicines
Otsuka also made an $88 million investment as part of the expansion. The companies plan to launch Abilify MyCite, approved in November 2017, by the end of this year.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
